| Product Code: ETC9963870 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) DNA & RNA Banking Services Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) DNA & RNA Banking Services Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) DNA & RNA Banking Services Market - Industry Life Cycle |
3.4 United States (US) DNA & RNA Banking Services Market - Porter's Five Forces |
3.5 United States (US) DNA & RNA Banking Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) DNA & RNA Banking Services Market Revenues & Volume Share, By Specimen Type, 2021 & 2031F |
3.7 United States (US) DNA & RNA Banking Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) DNA & RNA Banking Services Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 United States (US) DNA & RNA Banking Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and genetic testing |
4.2.2 Growing focus on precision medicine and genomic research |
4.2.3 Rising awareness about the importance of genetic data in healthcare |
4.3 Market Restraints |
4.3.1 High costs associated with DNA and RNA banking services |
4.3.2 Concerns regarding data privacy and security |
4.3.3 Regulatory challenges and uncertainties in the genetic testing industry |
5 United States (US) DNA & RNA Banking Services Market Trends |
6 United States (US) DNA & RNA Banking Services Market, By Types |
6.1 United States (US) DNA & RNA Banking Services Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Transportation Service, 2021- 2031F |
6.1.4 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Processing Service, 2021- 2031F |
6.1.5 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Storage Service, 2021- 2031F |
6.1.6 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Quality Control Service, 2021- 2031F |
6.1.7 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Data Storage, 2021- 2031F |
6.1.8 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) DNA & RNA Banking Services Market, By Specimen Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Blood, 2021- 2031F |
6.2.3 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Buccal Swabs & Hair Follicles, 2021- 2031F |
6.2.4 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) DNA & RNA Banking Services Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.3.3 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Drug Discovery & Clinical Research, 2021- 2031F |
6.3.4 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Clinical Diagnostics, 2021- 2031F |
6.3.5 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.4 United States (US) DNA & RNA Banking Services Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.4.3 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.4 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Hospitals & Diagnostic Centers, 2021- 2031F |
6.4.5 United States (US) DNA & RNA Banking Services Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) DNA & RNA Banking Services Market Import-Export Trade Statistics |
7.1 United States (US) DNA & RNA Banking Services Market Export to Major Countries |
7.2 United States (US) DNA & RNA Banking Services Market Imports from Major Countries |
8 United States (US) DNA & RNA Banking Services Market Key Performance Indicators |
8.1 Number of partnerships with healthcare providers for genetic testing services |
8.2 Adoption rate of DNA and RNA banking services by research institutions |
8.3 Percentage of population opting for genetic testing services |
8.4 Number of research studies utilizing genetic data for medical breakthroughs |
9 United States (US) DNA & RNA Banking Services Market - Opportunity Assessment |
9.1 United States (US) DNA & RNA Banking Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) DNA & RNA Banking Services Market Opportunity Assessment, By Specimen Type, 2021 & 2031F |
9.3 United States (US) DNA & RNA Banking Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) DNA & RNA Banking Services Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 United States (US) DNA & RNA Banking Services Market - Competitive Landscape |
10.1 United States (US) DNA & RNA Banking Services Market Revenue Share, By Companies, 2024 |
10.2 United States (US) DNA & RNA Banking Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here